Literature DB >> 35392240

Gene Expression and Mutational Landscape in a PMEC Patient With Low to Intermediate-High Grade Transition.

Weijie Dong1, Bing Zhu2, Yan You3, Bing Wang2, Dan Fu4, Daoxin Wang2, He Li1, Changyi Li1.   

Abstract

Primary pulmonary mucoepidermoid carcinoma (PMEC) is a very rare form of lung carcinoma. Due to the low incidence, little is known about its inherent genetic variation characteristics. The uniform treatment for PMEC has not been determined. In this case, we present a 45-year-old male with stage IA PMEC. The surgical specimens contained changes from low- to intermediate-to-high grade. We performed integrative analysis of whole-exome sequencing (WES-seq) and messenger ribonucleic acid sequencing (RNA-seq) to compare the molecular changes in the different lesions. Molecular testing exhibits the specimens harboring CRTC3-MAML2 fusion. The copy number gain of PDPK1 is only present in high-grade regional specimens. We also explored the level of immune infiltration by CIBERSORT. To our knowledge, this is the first report to describe a case of PMEC in the low- to intermediate-high-grade transition with multiomics analysis.
Copyright © 2022 Dong, Zhu, You, Wang, Fu, Wang, Li and Li.

Entities:  

Keywords:  CRTC1-MAML2 and CRTC3-MAML2 fusion; PDPK1; RNA-seq; WES-seq; primary pulmonary mucoepidermoid carcinoma

Year:  2022        PMID: 35392240      PMCID: PMC8980482          DOI: 10.3389/fonc.2022.820966

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  12 in total

Review 1.  PDK1: At the crossroad of cancer signaling pathways.

Authors:  Paolo Armando Gagliardi; Alberto Puliafito; Luca Primo
Journal:  Semin Cancer Biol       Date:  2017-05-01       Impact factor: 15.707

Review 2.  An update on grading of salivary gland carcinomas.

Authors:  Raja R Seethala
Journal:  Head Neck Pathol       Date:  2009-02-25

3.  Histopathologic, immunophenotypic and cytogenetic features of pulmonary mucoepidermoid carcinoma.

Authors:  Anja C Roden; Joaquín J García; Rebecca N Wehrs; Thomas V Colby; Andras Khoor; Kevin O Leslie; Longwen Chen
Journal:  Mod Pathol       Date:  2014-04-18       Impact factor: 7.842

4.  Mutational landscape of primary pulmonary salivary gland-type tumors through targeted next-generation sequencing.

Authors:  Fang Wang; Shao-Yan Xi; Wen-Wen Hao; Xin-Hua Yang; Ling Deng; Yu-Xia Xu; Xiao-Yan Wu; Liang Zeng; Kai-Hua Guo; Hai-Yun Wang
Journal:  Lung Cancer       Date:  2021-07-28       Impact factor: 5.705

5.  Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma.

Authors:  Takahisa Nakayama; Satoru Miyabe; Mitsukuni Okabe; Hidenori Sakuma; Kei Ijichi; Yasuhisa Hasegawa; Hitoshi Nagatsuka; Kazuo Shimozato; Hiroshi Inagaki
Journal:  Mod Pathol       Date:  2009-09-11       Impact factor: 7.842

6.  Robust enumeration of cell subsets from tissue expression profiles.

Authors:  Aaron M Newman; Chih Long Liu; Michael R Green; Andrew J Gentles; Weiguo Feng; Yue Xu; Chuong D Hoang; Maximilian Diehn; Ash A Alizadeh
Journal:  Nat Methods       Date:  2015-03-30       Impact factor: 28.547

7.  Clinical Characteristics and Prognosis of Patients With Pulmonary Mucoepidermoid Carcinoma: A SEER-Based Analysis.

Authors:  Lingxiao Qiu; Pan Song; Pingmei Chen; Huaqi Wang; Fangfang Li; Mengxuan Shu; Gen-Cheng Gong; Xiangjin Song; Chun Huang; Hongxia Jia; Nana Li; Guojun Zhang
Journal:  Front Oncol       Date:  2021-03-05       Impact factor: 6.244

8.  The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.

Authors:  Zirong Chen; Wei Ni; Jian-Liang Li; Shuibin Lin; Xin Zhou; Yuping Sun; Jennifer W Li; Marino E Leon; Maria D Hurtado; Sergei Zolotukhin; Chen Liu; Jianrong Lu; James D Griffin; Frederic J Kaye; Lizi Wu
Journal:  JCI Insight       Date:  2021-04-08

9.  Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer.

Authors:  Stefan Eser; Nina Reiff; Marlena Messer; Barbara Seidler; Kathleen Gottschalk; Melanie Dobler; Maren Hieber; Andreas Arbeiter; Sabine Klein; Bo Kong; Christoph W Michalski; Anna Melissa Schlitter; Irene Esposito; Alexander J Kind; Lena Rad; Angelika E Schnieke; Manuela Baccarini; Dario R Alessi; Roland Rad; Roland M Schmid; Günter Schneider; Dieter Saur
Journal:  Cancer Cell       Date:  2013-02-28       Impact factor: 31.743

10.  Prognostic impact of CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study.

Authors:  Yoshihide Okumura; Satsuki Nakano; Takayuki Murase; Kaori Ueda; Daisuke Kawakita; Toshitaka Nagao; Kimihide Kusafuka; Makoto Urano; Hidetaka Yamamoto; Satoshi Kano; Kiyoaki Tsukahara; Kenji Okami; Toru Nagao; Nobuhiro Hanai; Hiroshi Iwai; Ryo Kawata; Yuichiro Tada; Ken-Ichi Nibu; Hiroshi Inagaki
Journal:  Cancer Sci       Date:  2020-09-14       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.